COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 47
Predominant IgM Elevation
603
Predominant IgA Elevation
603
Predominant IgG Elevation
603
Mixed Antibody Patterns
603
Target Protein Pattern Analysis
604
S100B Antibodies
604
Claudin/Occludin Antibodies
604
Aquaporin-4 Antibodies
604
MMP Antibodies
604
Treatment Monitoring and Follow-Up
604
Expected Timeline for Antibody Resolution
604
Correlation with Clinical Improvement
604
Indicators for Treatment Modification
605
Long-Term Monitoring Strategy
605
Future Directions: Emerging Research and Applications
605
Advanced Biomarker Panels
605
Personalized Treatment Algorithms
605
Targeted Drug Delivery Systems
605
Regenerative Approaches
605
Microbiome-Based Interventions
605
Preventive Applications
606
Integration with Digital Health Technologies
606
Comprehensive Guide to Cyrex Array 22: Clinical Applications
and Integration with Other Functional Testing
629
What is Cyrex Array 22?
630
Comprehensive Markers Evaluated by Array 22
630
47
